Manoj Kumar Sharma

En s'appuyant sur les progr s r alis s dans d'autres disciplines, notamment l'ing nierie, la physique, la chimie et les math matiques/technologies de l'information, la biotechnologie, telle que nous la connaissons aujourd'hui, est l'amalgame id al de la "biologie" et de ses applications. Les innovations et les d veloppements r cents dans des domaines tels que le g nie g n tique, la biologie mol culaire et les OMICS, la biologie synth tique et la nanotechnologie ouvrent la voie la r alisation de divers crit res de s lection et la cr ation de microbes-m tabolites "sur mesure" qui peuvent tre utilis s avec succ s pour diverses applications. Au-del des tudes acad miques sur les micro-organismes, les plantes et les animaux, la biotechnologie est aujourd'hui utilis e dans une vari t d'industries "quotidiennes", y compris le secteur p trolier, les m dicaments, les cosm tiques, les nanotechnologies vertes et les applications environnementales, pour n'en citer que quelques-unes.

Durch die Nutzung von Entwicklungen in anderen Disziplinen, einschlie lich Ingenieurwesen, Physik, Chemie und Mathematik/Informationstechnologie, ist die Biotechnologie, wie wir sie heute kennen, die ideale Verschmelzung von "Biologie" und ihren Anwendungen. J ngste Innovationen und Entwicklungen in Bereichen wie Gentechnik, Molekularbiologie und OMICS, synthetische Biologie und Nanotechnologie ffnen die T r zur Erreichung verschiedener Auswahlkriterien und zur Schaffung "ma geschneiderter" Mikroben-Metaboliten, die erfolgreich f r verschiedene Anwendungen eingesetzt werden k nnen. ber die akademische Erforschung von Mikroorganismen, Pflanzen und Tieren hinaus wird die Biotechnologie heute in einer Vielzahl von "allt glichen" Industriezweigen eingesetzt, z. B. im Erd lsektor, in der Medizin, in der Kosmetik, in der gr nen Nanotechnologie und in Umweltanwendungen, um nur einige zu nennen.

Utilizzando gli sviluppi di altre discipline, tra cui l'ingegneria, la fisica, la chimica e la matematica/tecnologia dell'informazione, la biotecnologia, come la conosciamo oggi, l'amalgama ideale della "biologia" e delle sue applicazioni. Le recenti innovazioni e gli sviluppi in campi come l'ingegneria genetica, la biologia molecolare e le OMICS, la biologia sintetica e le nanotecnologie aprono ulteriormente le porte al raggiungimento di vari criteri di selezione e alla creazione di microbi-metaboliti "su misura" che possono essere utilizzati con successo per varie applicazioni. Al di l degli studi accademici su microrganismi, piante e animali, le biotecnologie sono oggi utilizzate in una variet di industrie "quotidiane", tra cui il settore petrolifero, i farmaci, i cosmetici, le nanotecnologie verdi e le applicazioni ambientali, solo per citarne alcune.

Ao empregar desenvolvimentos noutras disciplinas, incluindo engenharia, f sica, qu mica e matem tica/tecnologia da informa o, a biotecnologia, tal como a conhecemos hoje, a am lgama ideal da "biologia" e das suas aplica es. As recentes inova es e desenvolvimentos em campos como a engenharia gen tica, biologia molecular e OMICS, biologia sint tica e nanotecnologia abrem ainda mais a porta para a realiza o de v rios crit rios de selec o e a cria o de microbetabolitos " medida" que podem ser utilizados com sucesso para v rias aplica es. Para al m dos estudos acad micos de microrganismos, plantas e animais, a biotecnologia agora utilizada numa variedade de ind strias "do dia-a-dia", incluindo o sector petrol fero, medicamentos, cosm ticos, nanotecnologia verde, e aplica es ambientais, para citar algumas.

By employing developments in other disciplines, including engineering, physics, chemistry, and mathematics/information technology, biotechnology, as we know it today, is the ideal amalgam of "biology" and its applications. Recent innovations and developments in fields like genetic engineering, molecular biology and OMICS, synthetic biology, and nanotechnology further open the door to the achievement of various selection criteria and the creation of "tailor-made" microbe-metabolites that can be successfully used for various applications. Beyond academic studies of microorganisms, plants, and animals, biotechnology is now used in a variety of "day-to-day" industries, including the petroleum sector, medicines, cosmetics, green nanotechnology, and environmental applications, to name a few.

Nutrient imbalance in soils is an emerging threat to sustainable agriculture: intensive cultivation, use of poor quality groundwater, depletion of soil organic matter and excessive use of fertilizers are major reasons for poor soil fertility worldwide. This necessitates correct diagnosis of plant nutrient deficiencies to avoid further use of pesticides in cases where pests or pathogens that are not in fact the cause of poor crop health. Richly illustrated with 600 colour photographs, this book is a visual field identification guide for symptoms of most common nutrient deficiencies in field crops, covering all their stages of occurrence. Detailed descriptions and suggested for management practices are given with each entry.

The present book deals with various Small Area estimation techniques for estimating statistics of small geographical area. Application of discriminant function and principal component analysis has been demonstrated to scale down statistics from large level to small level through a linear model established at larger level. Small area level model has also been introduced to improve upon the estimates obtained from the application of discriminant function and principal component analysis. Various methods of cross validation of models fitted with the data have also been described to validate the models used to scale down estimates. Empirical investigation of various methodologies has been carried out with live data particularly on wheat production along with its related covariates for Sultanpur district of Uttar Pradesh, India. The book is quite useful for the policy makers to formulate agricultural development programmes at micro level, i.e. block/ panchyat level in order to enhance the agriculture productivity of the smaller area. The book will also work as reference to the researchers in small area estimation methods.

Dr Werner Frossmann in 1926, was the pioneer in introducing the concept of cardiac catheterization in human beings. Cardiac catheterization in the pediatric population was first reported by Dexter and his colleagues in 1947. Since, congenital heart diseases occur in 0.3% to 1.2% of all live births, the pediatric patients are therefore, the frequent visitors to our cardiac catheterization laboratory. The typical nature of the pediatric age group and the stringent requirements of the cardiac catheterization procedures warrant the need for a calm, motionless, anxiety-less and sedated patient. Various techniques of anaesthesia using different drugs independently or in combination have been tried till date but none has stood ideal so far. In this study, we evaluated Propofol and ketamine for their efficacy to achieve maximal and near to ideal criterias required for anaesthetizing pediatric patients undergoing diagnostic or interventional cardiac catheterization procedures. We also compared, evaluated and discussed their advantages and disadvantages on various parameters needed to accomplish an accurate cardiac chamber study for conducting various diagnostic and therapeutic interventions